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Background: Patients with untreated substance use disorders (SUDs) are at risk for frequent emergency
department visits and repeated hospitalizations. Project Engage, a US pilot program at Wilmington Hospital in
Delaware, was conducted to facilitate entry of these patients to SUD treatment after discharge. Patients identified
as having hazardous or harmful alcohol consumption based on results of the Alcohol Use Disorders Identification
Test-Primary Care (AUDIT-PC), administered to all patients at admission, received bedside assessment with
motivational interviewing and facilitated referral to treatment by a patient engagement specialist (PES). This
program evaluation provides descriptive information on self-reported rates of SUD treatment initiation of all
patients and health-care utilization and costs for a subset of patients.
Methods: Program-level data on treatment entry after discharge were examined retrospectively. Insurance claims
data for two small cohorts who entered treatment after discharge (2009, n = 18, and 2010, n = 25) were reviewed
over a six-month period in 2009 (three months pre- and post-Project Engage), or over a 12-month period in 2010
(six months pre- and post-Project Engage). These data provided descriptive information on health-care utilization
and costs. (Data on those who participated in Project Engage but did not enter treatment were unavailable).
Results: Between September 1, 2008, and December 30, 2010, 415 patients participated in Project Engage, and 180
(43%) were admitted for SUD treatment. For a small cohort who participated between June 1, 2009, and November
30, 2009 (n = 18), insurance claims demonstrated a 33% ($35,938) decrease in inpatient medical admissions, a 38%
($4,248) decrease in emergency department visits, a 42% ($1,579) increase in behavioral health/substance abuse
(BH/SA) inpatient admissions, and a 33% ($847) increase in outpatient BH/SA admissions, for an overall decrease of
$37,760. For a small cohort who participated between June 1, 2010, and November 30, 2010 (n = 25), claims
demonstrated a 58% ($68,422) decrease in inpatient medical admissions; a 13% ($3,308) decrease in emergency
department visits; a 32% ($18,119) decrease in BH/SA inpatient admissions, and a 32% ($963) increase in outpatient
BH/SA admissions, for an overall decrease of $88,886.
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Conclusions: These findings demonstrate that a large percentage of patients entered SUD treatment after
participating in Project Engage, a novel intervention with facilitated referral to treatment. Although the findings are
limited by the retrospective nature of the data and the small sample sizes, they do suggest a potentially
cost-effective addition to existing hospital services if replicated in prospective studies with larger samples and
controls.
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Alcohol and drug use are associated with a variety of
medical conditions [1,2] and carry high global burdens
of disease, injury, and cost [3,4]. Substance use is asso-
ciated with inadequate ambulatory care utilization and
poor health outcomes [5], and people with substance use
are over-represented among frequent consumers of
emergency department (ED) [6] and inpatient [7] me-
dical services. Substance abuse is predictive of discharge
against medical advice [8], and inpatients discharged
with substance use disorder (SUD) diagnoses, particu-
larly drug-related diagnoses, have higher rates of recur-
rent ED and medical inpatient service utilization [9].
This is not only associated with unnecessary human suf-
fering but also generates disproportionately high health-
care costs [10].
Hospital medical units are aggregators of people with
SUDs, and hospitalization itself could serve as a “reach-
able moment” to intervene with these patients and en-
gage them in appropriate SUD treatment after discharge
[11]. In-hospital interventions to help patients enter
SUD treatment might improve this situation, and such
programs are likely to receive heightened attention since
the Patient Protection and Affordable Care Act [12] will
reduce Medicare payments to hospitals with excess read-
missions beginning in October 2012.
In September 2008, leadership at Wilmington Hospital
in the US state of Delaware collaborated with Brandy-
wine Counseling and Community Services (BCCS), a
major provider of SUD treatment in Delaware, to de-
velop and implement Project Engage, a pilot program to
identify medical and surgical inpatients with problematic
substance use and to help them enter SUD treatment
after discharge. Wilmington Hospital is a 241-bed ge-
neral hospital owned and operated by Christiana Care
Health System (CCHS), one of the largest health-care
providers in the US mid-Atlantic region. Christiana Care
Health System serves the state of Delaware and portions
of seven New Jersey, Pennsylvania, and Maryland coun-
ties. In 2011, Wilmington Hospital recorded 52,178 ED
visits and 13,778 medical and surgical admissions.
Project Engage has its theoretical basis in the literature
on brief intervention (BI) to address excessive alcoholuse among primary care outpatients [13]; BI for risky
drinking and alcohol dependence among medical inpati-
ents [14,15]; and screening, BI, and referral to treat-
ment (SBIRT) for patients with moderate to high risk
alcohol and/or drug use or dependence in diverse me-
dical settings, including primary care, EDs, trauma cen-
ters, and inpatient and outpatient medical hospital
services [16-18].
Studies reported in this literature have had promising
outcomes. Patients in a large, federally funded SBIRT
study conducted in six states reported decreases in illicit
drug and heavy alcohol use subsequent to participation
[16]. Studies of SBIRT in EDs have demonstrated
decreased health-care costs and inpatient utilization [17]
and increased rates of admissions to SUD treatment
[19]. Randomized trials of BI for excessive alcohol use
among primary care outpatients [13] have shown signifi-
cant reductions in self-reported drinking. Data from
screening and BI (SBI) for primary care outpatients with
unhealthy nondependent alcohol use [13] led the US
Joint Commission on Accreditation of Healthcare Orga-
nizations (JCAHO) to include performance measures for
its use in hospitals [20].
Although these lines of research are significant, they
have important gaps. For example, most published stu-
dies have applied BI to patients with unhealthy or risky
drinking, alcohol abuse, and/or alcohol dependence. In
reality, alcohol and drug problems are frequently comor-
bid, and patients with alcohol and drug problems—or
primary drug problems—are also in need of care. Fur-
ther, the majority of BI studies demonstrated efficacy in
reducing alcohol use when alcohol-dependent indivi-
duals were excluded [21,22]; however, patients with alco-
hol dependence constitute the majority of medical
inpatients with alcohol problems [23] and have a great
need for SUD treatment. A literature search revealed a
paucity of published studies of alcohol and drug BI or
SBIRT conducted exclusively with hospital inpatients. Fi-
nally, hospitalized patients with SUDs often face mul-
tiple barriers to accessing treatment including
homelessness, brief lengths of stay complicating dis-
charge planning, ambivalence, and inadequate transfer
resources [24]. These problems require an increased
Pecoraro et al. Addiction Science & Clinical Practice 2012, 7:20 Page 3 of 7
http://www.ascpjournal.org/content/7/1/20emphasis on referral to treatment. Since the chances of
engaging patients in treatment decrease with the length
of time between assessment and treatment admission
[25], facilitated admission could be particularly important
for this population.
Description of the project engage pilot program
In many cases, SUDs directly or indirectly contribute to
health problems leading to hospitalization. Patients with
SUDs are often well known to hospital staff, but clinical
teams typically have little training or experience in
addressing SUDs. In fact, hospital personnel are often
frustrated with these patients due to frequent rehospita-
lizations, noncompliance with recommendations to cut
back or abstain, and resistance to entering and staying in
SUD treatment. Project Engage, a modified version of BI
and SBIRT, was designed to provide bedside assistance
for the clinical team to address these problems. It con-
sists of SUD identification by hospital staff based on
clinical impressions but without a universal standardized
screening process to identify alcohol and drug problems,
followed by BI and facilitated referral to treatment
(FRT). Although there are efforts to identify patients,
this does not constitute “screening” because a universal,
standardized approach to identification is not employed.
Referral to treatment is enhanced by facilitation. The
Project Engage pilot program described here was not
designed as a research study, although self-report data
on initiation of SUD treatment by Project Engage
patients after discharge were collected, and insurance-
claims data on two small cohorts of patients were exam-
ined retrospectively.
Identification
Hospital clinical staff identified patients with possible alco-
hol and/or drug problems per usual procedures. Before
Project Engage was initiated, brief trainings were provided
to nursing staff on how to identify patients with problem-
atic drug or alcohol use. The potential value of connecting
them to treatment was emphasized, and an overview of
the Project Engage program along with contact informa-
tion for Project Engage staff was provided. In October
2009, the Alcohol Use Disorders Identification Test-
Primary Care (AUDIT-PC) [26-28], a five-item self-report
instrument to detect “hazardous and harmful alcohol con-
sumption [29],” was initiated system-wide at CCHS to de-
tect patients at risk for alcohol withdrawal and delirium
tremens (DTs), and nursing staff administered it to all
medical/surgical inpatients at admission.
Patients were identified for possible inclusion in Project
Engage if they met any of the following criteria: clinical
suspicion of alcohol and/or drug abuse or dependence;
hospital admission likely related to alcohol and/or drug
abuse or dependence; positive result on a drug test;AUDIT-PC≥ 5 (as of October 2009); primary, secondary,
or tertiary diagnosis related to substance use; or self-
reported past or current alcohol and/or drug use. Patients
under age 18 or with senility, dementia, or other disorders
that interfered with the ability to provide informed con-
sent to be seen by a non-CCHS provider were excluded
from Project Engage. Nursing staff provided eligible
patients with a choice to participate—or not participate—
in Project Engage. Although Project Engage was not a re-
search study, patients who chose to participate in it signed
a “Choice Form” as part of an informed-consent process
required in order to be seen by a non-CCHS provider.
(The patient engagement specialists [PESs] were employed
by BCCS.) Unfortunately, the number of patients who
were identified and approached for participation, the
number of interventions received by each patient, and the
number of Project Engage patients who were unwilling to
accept a referral were not recorded.
Brief intervention
Patients who chose to participate in Project Engage
received a BI from a PES hired specifically for the pro-
ject. Project Engage specialists were in stable recovery
from alcohol and/or drugs (at least two years without
drug or alcohol use) and selected on the basis of emo-
tional stability, experience in recovery, and interpersonal
strengths. They received training in working in a health-
care setting, co-occurring disorders, rapport building,
basic interviewing techniques, assessment, motivational
interviewing (MI), treatment referral, and ethics and were
regularly supervised by licensed chemical-dependency
professionals.
The BI occurred while patients were hospitalized and
consisted of rapport building, a brief assessment, and
one or two brief motivational interviewing (MI) sessions
[30] to enhance patient motivation to attend SUD treat-
ment and accept a facilitated referral. The purpose of
the assessment was to determine if patients might bene-
fit from SUD treatment and to identify possible barriers
to transitioning them into it. The PESs used the Dela-
ware Division of Substance Abuse and Mental Health
(DSAMH) Co-Occurring Conditions Screening Instru-
ment in conjunction with information gathered during
MI sessions and the DSAMH/American Society of Ad-
diction Medicine (ASAM) Crosswalk to match patient
treatment needs to treatment programs according to
ASAM’s Patient Placement Criteria-2nd Revision
(ASAM PPC-2R [31]). If treatment slots in appropriate
Delaware programs were not available, patients received
facilitated referrals to programs in neighboring states.
Facilitated referral to treatment
When patients were willing to consider SUD treatment,
the PESs provided them with facilitated referrals as
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and when patients agreed to consider a program, the
PESs determined whether that program had an open-
ing, whether it accepted the patient’s insurance or
could admit him/her with other funding, and (if both
these conditions were met) made an appointment for
a time that was convenient to the patient. Patients
who were in need of treatment and willing to accept
a referral received a date and time for an appoint-
ment or inpatient admission rather than the name
and phone number of a program. For programs that
required the Addiction Severity Index [32], PESs
administered it at bedside if patients were willing to
complete it. The PESs also assessed potential barriers
to treatment initiation such as homelessness, transpor-
tation difficulties, or lack of appropriate clothing.
When necessary, patients were given bus or train tick-
ets, driven to the treatment program, or picked up by
the treatment program upon discharge. The PESs also
contacted shelters for housing, acquired clothing for
patients in need, and called patients within 48 hours
after their scheduled admission or appointment to
confirm that they attended. When patients reported
having gone to treatment, PESs gave positive feedback
and encouraged them to continue; when patients
reported that they had not gone to treatment, PESs
attempted to problem-solve any barriers and left the
door open for future contact to facilitate admissions
or appointments.
Methods
The Project Engage pilot at Wilmington Hospital was
not prospectively designed as a research study; however,
program-level data on patients’ self-reported initiation of
SUD treatment, as well as a description of health-care
utilization before and after the intervention for two
small cohorts of Project Engage patients who entered
SUD treatment, were available from a single health plan
and are presented here.
Participants
Participants included all Project Engage patients seen
between 9/1/2008 and 12/30/2010 (n = 415) as well as
two smaller groups of patients who received the Project
Engage intervention, initiated SUD treatment after dis-
charge, and had uninterrupted insurance coverage and
complete claims data three months before and three
months after the intervention (2009 group) (n = 18) or
six months before and six months after the intervention
(2010 group) (n = 25).
Of the 415 patients seen between September 1, 2008,
and December 30, 2010, 275 (65%) were male, and 135
(33%) were female (5 did not self-identify as either gen-
der); 201 (48%) were white, 188 (45%) were black, and26 (6%) self-identified as mixed race or other. The ave-
rage age of patients was 46 years (SD, 11.8 years), and
183 (44%) were ≥50 years. Regarding their primary sub-
stance of choice (some were multiple), 240 (58%)
reported alcohol, 90 (22%) reported crack or powder co-
caine, 64 (15%) reported heroin, 17 (4%) reported
marijuana, 11 (3%) reported an opioid other than heroin,
5 (0.01%) reported benzodiazepines, and 4 (0.01%)
reported methamphetamines.
The two smaller cohorts consisted of all patients
insured by Delaware Physicians Care Incorporated
(DPCI) who had uninterrupted coverage and complete
claims data. The 2009 cohort participated in Project En-
gage between June 1, 2009, and November 30, 2009, and
consisted of nine men and nine women. The average
age was 43 years (SD, 10 years). The 2010 cohort par-
ticipated in Project Engage between June 1, 2010, and
November 30, 2010, and consisted of 12 men and 13
women. The average age was 40 years (SD, 12 years).
Unfortunately, the small number of patients meeting
inclusion criteria (uninterrupted coverage and complete
claims data) did not allow for random selection.Data analytic strategy
Brandywine Counseling and Community Services fur-
nished program-level data on the number of patients
who participated in Project Engage between September
1, 2008, and December 30, 2010, and on self-reported
SUD treatment initiation after discharge. Delaware Phy-
sicians Care Incorporated provided claims data for two
smaller cohorts. Christiana Care Health System’s Institu-
tional Review Board approved queries to BCCS’s Project
Engage records to determine rates of treatment initiation
and the use of data from DPCI’s reports for a poster
presentation [33] and this article. Unfortunately, the
DPCI datasets from which the reports were generated
were not available to the authors, so detailed health eco-
nomic analyses were not possible.Results
Program-level data: Participant admissions to SUD
treatment
Between September 1, 2008, and December 30, 2010,
415 patients participated in Project Engage. (The num-
ber of patients identified and approached for participa-
tion was not recorded.) Of these patients, 180 (43%)
were admitted to an inpatient treatment program and/or
attended one or more session(s) at an outpatient pro-
gram. Of these patients, 16 (8%) were admitted to in-
patient detoxification; 53 (29%) were admitted to
residential treatment; 103 (57%) were admitted to out-
patient treatment; and 8 (4%) were admitted to transi-
tional housing and treatment (Table 1).
Table 1 Admissions to substance abuse treatment for
project engage patients seen between September 1,
2008, and December 30, 2010 (N= 415)
Admitted to a Substance Abuse Treatment Program 180 (43%)
- Inpatient Detoxification 16/180 (8%)
- Residential Treatment 53/180 (29%)
- Outpatient 103/180 (57%)
- Transitional Housing and Outpatient 8/180 (4%)
Pecoraro et al. Addiction Science & Clinical Practice 2012, 7:20 Page 5 of 7
http://www.ascpjournal.org/content/7/1/20Cohort-level data: Health-care utilization and costs before
and after participation in project engage
Delaware Physicians Care Incorporated provided health-
care utilization and costs for inpatient medical admissions,
ED visits, and inpatient and outpatient behavioral health/
substance abuse (BH/SA) admissions before and after the
2009 and 2010 subgroups received the Project Engage
intervention (DPCI was not able to differentiate be-
tween BH and SA treatment in reported outcomes). The
hospitalization during which patients received the Project
Engage intervention was not included in these costs, but
SUD treatment costs after hospitalization were included.
Of the 18 patients in 2009 subgroup who initiated
SUD treatment after discharge, five had at least one BH/
SA outpatient visit subsequent to the Project Engage
intervention, and six had at least one inpatient BH/SA
admission. There was a 33% ($35,938) decrease in in-
patient medical admissions in this subgroup, a 38%
($4,248) decrease in ED visits, a 42% ($1,579) increase in
BH/SA inpatient admissions, and a 33% ($847) increase
in outpatient BH/SA admissions, for an overall cost de-
crease of $37,760 (Table 2).
Of the 25 patients in the 2010 subgroup who initiated
SUD treatment after discharge, 13 had at least one BH/
SA outpatient visit subsequent to the Project Engage
intervention, and 9 had at least one inpatient BH/SA ad-
mission. a 58% ($68,422) decrease in inpatient medical
admissions; a 13% ($3,308) decrease in emergencyTable 2 Health care utilization among patients in the 2009 an
Subgroup
Pre-Interv
Inpatient Medical Admissions 1
Emergency Department Visits 5
Inpatient Behavioral Health/Substance Abuse Admissions
Outpatient Behavioral Health/Substance Abuse Admissions 1
2010 Subgrou
Pre-Interv
Inpatient Medical Admissions 1
Emergency Room Visits 1
Inpatient Behavioral Health/Substance Abuse Admissions 2
Outpatient Behavioral Health/Substance Abuse Admissions 2department visits; a 32% ($18,119) decrease in BH/SA
inpatient admissions, and a 32% ($963) increase in out-
patient BH/SA admissions, for an overall decrease of
$88,886 (Table 2).
Discussion
Although this pilot program was not designed as a re-
search study, retrospective evaluation of the data yielded
useful descriptive information. Project Engage involved
collaboration between a large hospital system, an SUD
treatment provider, and a health plan and demonstrated
that such collaboration is possible in a clinical setting. It
also demonstrated that cost data (although limited) can
be obtained outside the context of a formal research
study. Importantly, FRT (a major component of Project
Engage) is an innovative approach that warrants further
study to assess its impact on treatment enrollment. The
use of PESs rather than graduate students or licensed
clinicians differs from approaches common in the exist-
ing BI and SBIRT literature. The success of Project En-
gage suggests interventions delivered by such individuals
are accepted by patients and could be used in these and
other settings.
The finding that a relatively large proportion (43%) of
Project Engage patients entered SUD treatment after dis-
charge is promising. Krupski et al. [19] examined admis-
sions to treatment subsequent to BI (MI without referral
to treatment) in ED patients who screened positive for
alcohol and/or other drug problems and found that 34%
of those who received the intervention were admitted to
SUD treatment within 12 months compared with 23% of
those who did not receive it. Saitz et al. [14] studied a BI
(single MI session without referral to treatment) for
medical inpatients with risky drinking or alcohol de-
pendence and found that, among alcohol-dependent
patients, 49% of the MI group and 44% of the control
group attended alcohol treatment within three months;
between-group differences were not significant. Ourd 2010 project engage subgroups
(N = 18)
ention (n) Post-Intervention (n) Difference
2 8 33% decrease ($35,938)
4 33 38% decrease ($4,248)
7 10 42% increase ($1,579)
2 16 33% increase ($847)
p (N=25)
ention (n) Post-Intervention (n) Difference
7 7 58% decrease ($68,422)
33 116 12.7% decrease ($3,308)
8 19 32% decrease ($18,119)
5 33 32% increase ($963)
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have had alcohol and/or drug abuse and dependence
and were collected within 48 hours of patients’ sche-
duled admissions or appointments. It is possible that
these numbers could have changed three or 12 months
after the intervention.
The preliminary findings concerning apparent differ-
ences in health-care costs before and after the interven-
tion in the two smaller patient cohorts are also
encouraging, as they reflect less medical and more BH/
SA treatment utilization in the post-hospitalization
period; however, they cannot definitively be considered
cost savings due to a number of limitations. These in-
clude the absence of formal substance-use diagnoses; the
lack of a control condition; the retrospective nature of
data collection; the lack of data on the number of
patients approached who declined to participate in Pro-
ject Engage; the lack of data on the number of patients
for whom a referral to treatment was not considered ne-
cessary; and differences in the specific characteristics of
facilitated referrals. Because of these limitations, no con-
clusions can be drawn about causation. Also, the data on
health-care costs were based on previously completed
reports, the datasets for which were not released to the
authors; thus further analyses were not possible.
Based on available findings, one can only conclude
that a relatively large number (43%) of patients who
received the Project Engage intervention entered SUD
treatment, and differences in overall health-care costs
were observed after participation. It is possible that these
outcomes were affected by selection bias in that those
patients who were most likely to participate in Project
Engage and enter SUD treatment were also less likely to
utilize medical health-care services. However, according
to the literature, hospitalized patients like those who
participated in Project Engage have not accessed sub-
stance abuse treatment by the usual referral processes.
From the authors’ perspective, it is possible that en-
gaging these patients in SUD treatment reduced their
health-care utilization and costs by addressing their
SUDs; however, this is impossible to prove due the li-
mitations of these data. From the perspective of the
payer, creating a portal for these patients to enter addic-
tion treatment makes sense as a potential way to reduce
health-care costs.
Conclusions
Despite limitations, these results provide useful pilot
data to justify prospective, controlled studies of similar
interventions including FRT for medically hospitalized
patients. Key next steps for Project Engage include refi-
ning the model to incorporate lessons learned; identifying
potential sources of support; and examining potential
pre-/post-participation differences in health-care costswith appropriate economic analyses. A standardized ap-
proach to screening may help hospital clinical staff to
identify more patients in the future. It would also be use-
ful to examine the role of FRT in greater detail. Rando-
mized controlled trials comparing an intervention with
FRT to an intervention without FRT are necessary. To in-
crease the accuracy of endpoint measurement, it would be
helpful to collect outcome data at six-months post-
discharge that includes confirmation of attendance at
treatment programs, self-reported substance use, urinaly-
sis, and breath testing. Finally, this study looked at admis-
sions to SUD treatment, not retention. It is well known
that many patients admitted to addiction treatment do
not remain in treatment [34]. Subsequent studies should
investigate both admissions and retention. If retention is
problematic, an adaptive continuing care component [35]
could be added to future iterations of the Project Engage
intervention. Due to these favorable initial findings
described here and anonymous financial support, Project
Engage was retained at Wilmington Hospital and initiated
at Christiana Hospital in the fall of 2011. A prospective
study of the intervention is underway.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
AP coordinated inter-institutional collaboration for this program evaluation,
reviewed the literature, drafted and edited the manuscript, guided queries
on specific data points by BCCS and DPCI where possible, and prepared the
manuscript for submission. TH developed the idea for Project Engage,
collaborated with community partners, implemented the program at
Wilmington Hospital, reviewed the literature, and reviewed and edited paper.
EE reviewed and edited the manuscript. JB reviewed and edited the
manuscript and helped to identify endpoints for future studies. PAW
coordinated DPCI’s collaboration with Wilmington Hospital, provided reports
on data analyses that were incorporated into the manuscript, and reviewed
and edited the manuscript. BS led the BCCS team, trained and supervised
the PESs, managed program-level data, participated in meetings between
CCHS and BCCS staff, and reviewed and edited the manuscript. PM wrote
the IRB application and reviewed and edited the manuscript. GW drafted
and edited the manuscript. All authors read and approved the final
manuscript.
Financial support
This research was supported by a Christiana Care Community Services and
Education Grant (Project Engage), NIDA grant U10 DA-13043 (AP), and NIDA
U10 DA-13043 and KO5 DA-17009 (GW).
Acknowledgments
We wish to acknowledge DPCI and BCCS; Bobbi Dillard, the PES during most
of Project Engage’s pilot phase; and all of the clinical staff at Wilmington
Hospital for contributing to the success of this pilot project. We also wish to
thank all of the patients who participated in the program. We wish to thank
the Carol A. Ammon Foundation for its ongoing, generous support of
Project Engage.
Author details
1Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA,
USA. 2Clinical Trials Network, Delaware Valley Node, Wilmington, DE, USA.
3Christiana Care Health System and Wilmington Hospital, Wilmington, DE,
USA. 4Delaware Physicians Care Incorporated, Wilmington, DE, USA.
5Brandywine Counseling and Community Services, Wilmington, DE, USA.
Pecoraro et al. Addiction Science & Clinical Practice 2012, 7:20 Page 7 of 7
http://www.ascpjournal.org/content/7/1/206Bryn Mawr Graduate School of Social Work and Social Research, Bryn Mawr,
PA, USA.
Received: 26 August 2011 Accepted: 7 September 2012
Published: 25 September 2012References
1. Brick J: Medical consequences of alcohol abuse. In Handbook of Medical
Consequences of Alcohol and Drug Abuse. Edited by Brick J. Binghamton, NY:
Haworth Medical Press; 2004:7–31.
2. Han B, Gfroerer JC, Colliver JD: Associations between duration of illicit
drug use and health conditions: results from the 2005–2007 national
surveys on drug use and health. Ann Epidemiol 2010, 20(4):289–297.
3. Rehm J, Mothers C, Popova S, Thavorncharoensap M, Teerawattananon Y,
Patra J: Global burden of disease and injury and economic cost
attributable to alcohol use and alcohol-use disorders. Lancet 2009,
373(9682):2223–2233.
4. World Health Organization: The global burden of disease: 2004 update.
Geneva, Switzerland: World Health Organization; 2008. http://www.who.int/
healthinfo/global_burden_disease/GBD_report_2004update_full.pdf
5. Baldwin WA, Rosenfeld BA, Breslow MJ, Buchman TG, Deutschman CS,
Moore RD: Substance-abuse related admissions to adult intensive care.
Chest 1993, 103:21–25.
6. Cherpitel CJ, Ye Y: Drug use and problem drinking associated with
primary care and emergency room utilization in the United States
general population. Drug Alcohol Depend 2008, 97(3):226–230.
7. Billings J, Mijanovich T: Improving the management of care for high-cost
Medicaid patients. Health Aff 2007, 26:1643–1654.
8. Alfandre DJ: "I’m going home”: discharges against medical advice. Mayo
Clin Proc 2009, 84(3):255–260.
9. Walley AY, Paasche-Orlow M, Lee EC, Forsythe S, Chetty VK, Mitchell S, Jack BW:
Acute care hospital utilization among medical inpatients. J Addict Med 2012,
6:50–56.
10. Schrag D, Feng X, Hanger M, Elkin E, Bickell N, Black P: Fragmentation of care
for frequently hospitalized urban residents. Med Care 2006, 44:560–567.
11. Shanahan CW, Beers D, Alford DP, Brigandi E, Samet JH: A transitional
opioid program to engage hospitalized drug users. J Gen Intern Med
2010, 25:803–808.
12. Patient Protection and Affordable Care Act (HR 3590). http://democrats.senate.
gov/reform/patient-protection-affordable-care-act-as-passed.pdf
13. Kaner EF, Dickinson HO, Beyer FR, Campbell F, Schlesinger C, Heather N,
Saunders JB, Burnand B, Pienaar ED: Effectiveness of brief alcohol
interventions in primary care populations. Cochrane Database Syst Rev
2007, 2:CD004148.
14. Saitz R, Palfai TP, Cheng DM, Horton NJ, Freedner N, Dukes K, Kraemer KL,
Roberts MS, Guerriero RT, Samet JH: Brief intervention for medical
inpatients with unhealthy alcohol use: A randomized, controlled trial.
Ann Intern Med 2007, 146(3):167–176.
15. Saitz R, Palfai TP, Cheng DM, Horton NJ, Dukes K, Kraemer KL, Roberts MS,
Guerriero RT, Samet JH: Some medical inpatients with unhealthy alcohol
use may benefit from brief intervention. J Stud Alcohol Drugs 2009,
70(3):426–435.
16. Madras BK, Compton WM, Avula D, Stegbauer T, Stein JB, Clark HW:
Screening, brief interventions, referral to treatment (SBIRT) for illicit drug
and alcohol use at multiple health-care sites: Comparison at intake and
6 months later. Drug Alcohol Depend 2009, 99:280–295.
17. Estee S, Wickizer T, He L, Ford Shah M, Mancuso D: Evaluation of the
washington state screening, brief intervention, and referral to treatment
project: cost outcomes for Medicaid patients screened in hospital
emergency departments. Med Care 2010, 48:18–24.
18. Bernstein E, Bernstein JA, Stein JB, Saitz R: SBIRT in emergency care
settings: are we ready to take it to scale? Acad Emerg Med 2009,
16(11):1072–1077.
19. Krupski A, Sears JM, Joesch JM, Estee S, He L, Dunn C, Huber A, Roy-Byrne P,
Ries R: Impact of brief interventions and brief treatment on admissions to
chemical dependency treatment. Drug Alcohol Depend 2010, 110:126–136.
20. Saitz R: Candidate performance measures for screening for, assessing,
and treating unhealthy substance use in hospitals: Advocacy or
evidence-based practice? Ann Intern Med 2010, 153(1):40–43.21. Freyer J, Coder B, Bischof G, Baumeister SE, Rumpf HJ, John U, Hapke U:
Intention to utilize formal help in a sample with alcohol problems: a
prospective study Drug Alcohol Depend 2007, 37:210–216.
22. Holloway AS, Watson HE, Arthut AJ, Starr G, McFayden AK, McIntosh J: The
effect of brief interventions on alcohol consumption among heavy
drinkers in a general hospital setting. Addiction 2007, 102:1762–1770.
23. Saitz R, Freedner N, Horton NJ, Samet JH: The severity of unhealthy
alcohol use in hospitalized medical patients. The spectrum is narrow.
J Gen Intern Med 2006, 21:381–385.
24. Raven MC, Carrier ER, Lee J, Billings JC, Marr M, Gourevitch MN:
Substance use treatment barriers for patients with frequent hospital
admissions. J Subst Abuse Treat 2010, 38(1):22–30.
25. Hoffman KA, Ford JH, Tillotson CJ, Choi D, McCarty D: Days to treatment
and early retention among patients in treatment for alcohol and drug
disorders. Addict Behav 2011, 36:643–647.
26. Aertgeerts B, Buntinx F, Ansoms S, Fevery J: Questionnaires are better than
laboratory tests to screen for current alcohol abuse or dependence in a
male inpatient population. Acta Clin Belgica 2002, 57:241–249.
27. Gomez A, Conde A, Santana JM, Jorrin A: Diagnostic usefulness of brief
versions of Alcohol Use Disorders Identification Test (AUDIT) for
detecting hazardous drinkers in primary care settings. J Stud Alcohol
2005, 66:305–308.
28. Piccinelli M, Tessari E, Bortolomasi M, Piasere O, Semenzin M, Garzotto N,
Tansella M: Efficacy of the alcohol use disorders identification test as a
screening tool for hazardous alcohol intake and related disorders in
primary care: A validity study. Brit Med J 1997, 314:420–424.
29. Saunders JB, Aasland OG, Amundsen A, Grant M: Alcohol consumption and
related problems among primary health care patients: WHO
Collaborative Project on Early Detection of Persons with Harmful Alcohol
Consumption–I. Addiction 1993, 88:349–362.
30. Miller WR, Rollnick S: Motivational Interviewing: Preparing People for Change.
2nd edition. New York: Guilford Press; 2002.
31. Center for Substance Abuse Treatment (CSAT): Treatment Improvement
Protocol (TIP) 42 for Substance Abuse Treatment for Persons with Co-Occurring
Disorders. US: Department of Health and Human Services, Substance Abuse
and Mental Health Services Administration, Center for Substance Abuse
Treatment; 2005. DHHS Publication No. (SMA) 05–3992.
32. McLellan AT, Cacciola JC, Alterman AI, Rikoon SH, Carise D: The Addiction
Severity Index at 25: Origins, contributions and transitions. Am J
Addictions 2006, 15:113–124.
33. Horton T, Woody GE, Pecoraro A, Wright P, Silverman B: Project Engage:
SBIRT with Medically Hospitalized Patients. Proceedings of the College on
the Problems of Drug Dependence 2011, 77. http://www.cpdd.vcu.edu/Pages/
Meetings/CPDD11AbstractBook.pdf
34. Substance Abuse and Mental Health Services Administration OAS: Treatment
episode data set (TEDS): 2005. Discharges from substance abuse treatment
services. Rockville, MD: Substance Abuse and Mental Health Services
Administration; 2008.
35. McKay JR: Treating Substance Use Disorders with Adaptive Continuing Care.
Washington, DC: American Psychological Association; 2009.
doi:10.1186/1940-0640-7-20
Cite this article as: Pecoraro et al.: Early data from project engage: a
program to identify and transition medically hospitalized patients into
addictions treatment. Addiction Science & Clinical Practice 2012 7:20.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
